Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy”
or the “Company”), maker of Battle Born Batteries™ and an
industry leader in energy storage, has continued to invest in the
development of battery cell manufacturing with cutting-edge
research equipment from Bruker Corporation (“Bruker”) (Nasdaq:
BRKR).
Dragonfly Energy uses Bruker’s nuclear magnetic
resonance (“NMR”)-based equipment to study lithium batteries at a
fundamental level. Through NMR, battery scientists can pull
electrolyte samples at various points during the lifetime of a
battery for various measurements, which could optimize the
performance of cells produced using the Company’s patented dry
electrode process. The Company recently announced the completion of
its domestic cell manufacturing pilot line and expects to produce
full cells by the end of 2023.
“The performance and long-term behavior of
lithium ion batteries depend on nanoscale structures that form and
evolve over the lifetime of the batteries. It has been integral to
our mission to build a world class battery lab to better observe
these structures, as we develop new manufacturing processes and
explore new materials for storage applications,” Dragonfly Energy
Chief Executive Officer Dr. Denis Phares said. “Bruker has a
reputation for building some of the most advanced equipment in the
world. We believe that by working closely with them, we are able to
innovate and develop batteries that meet strict safety and
performance requirements, allowing the widespread deployment of
cost-effective energy storage on and off the grid.”
For more than ten years, with over fifty-five
filed and pending patents, and hundreds of thousands of battery
packs already in the field, Dragonfly Energy is a comprehensive
lithium battery and energy storage technology company. A critical
part of maintaining this technology leadership is making sure their
expert team of scientists have access to leading-edge
instrumentation.
“A lithium ion battery is a very complex and
dynamic system when cycling,” Dr. Vick Singh, Director of Research
and Development at Dragonfly Energy, said. “With this new,
cutting-edge instrumentation, we believe we are gaining valuable
insights into chemistry and manufacturing optimization which is
allowing us to make rapid strides in new cell designs and
chemistries.”
Numerous technologies among Bruker’s extensive
product portfolio have been utilized in Dragonfly’s advancements
with lithium battery cells, including AFM, FT-IR, NMR, Raman, XRD,
and XRF, among others.
"We are excited to cooperate with Dragonfly
Energy and showcase how our various analytical technologies provide
value for the different stages of the battery cell value chain,”
commented Dr. Joerg Koehler, Head of Business Unit Industrial
Analysis at Bruker BioSpin. “Understanding the chemical processes
and optimizing materials is essential for optimal battery
performance. Therefore, providing a comprehensive solution for
material characterization suitable for both research and quality
control in manufacturing is crucial. Bringing the talented teams of
Bruker and Dragonfly Energy together and sharing these objectives
we believe will ultimately, redefine renewable energy storage."
To learn more about Dragonfly Energy, visit
DragonflyEnergy.com.
About Dragonfly EnergyDragonfly
Energy Holdings Corp. (Nasdaq: DFLI) headquartered in Reno, Nevada,
is a leading supplier of deep cycle lithium-ion batteries.
Dragonfly Energy’s research and development initiatives are
revolutionizing the energy storage industry through innovative
technologies and manufacturing processes. Today, Dragonfly Energy’s
non-toxic deep cycle lithium-ion batteries are displacing lead-acid
batteries across a wide range of end-markets, including RVs, marine
vessels, off-grid installations, and other storage applications.
Dragonfly Energy is also focused on delivering an energy storage
solution to enable a more sustainable and reliable smart grid
through the future deployment of its proprietary and patented
solid-state cell technology. To learn more,
visit www.dragonflyenergy.com/investors.
About Bruker Corporation Bruker
(Nasdaq: BRKR) is enabling scientists to make breakthrough
discoveries and develop new applications that improve the quality
of human life. Bruker’s high performance scientific instruments and
high value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular and cell biology research, in applied and pharma
applications, in microscopy and nanoanalysis, as well as in
industrial applications. Bruker offers differentiated, high-value
life science and diagnostics systems and solutions in preclinical
imaging, clinical phenomics research, proteomics and multiomics,
spatial and single-cell biology, functional structural and
condensate biology, as well as in clinical microbiology and
molecular diagnostics. For more information, please visit:
www.bruker.com.
Forward-Looking StatementsThis
press release contains forward-looking statements within the
meaning of the United States Private Securities Litigation Reform
Act of 1995. Forward-looking statements include all statements that
are not historical statements of fact and statements regarding the
Company’s intent, belief, or expectations, including, but not
limited to, statements regarding the Company’s equipment or
relationship with Bruker Corporation, the Company’s future results
of operations and financial position, planned products and
services, business strategy and plans, market size and growth
opportunities, competitive position and technological and market
trends. Some of these forward-looking statements can be identified
by the use of forward-looking words, including “may,” “should,”
“expect,” “intend,” “will,” “estimate,” “anticipate,” “believe,”
“predict,” “plan,” “targets,” “projects,” “could,” “would,”
“continue,” “forecast” or the negatives of these terms or
variations of them or similar expressions.
These forward-looking statements are subject to
risks, uncertainties, and other factors (some of which are beyond
the Company’s control) which could cause actual results to differ
materially from those expressed or implied by such forward-looking
statements. Such factors include those set forth in the sections
entitled “Risk Factors” and “Cautionary Note Regarding
Forward-Looking Statements” in the Company’s Annual Report on Form
10-K for the year ended December 31, 2022 and in the Company’s
subsequent filings with the SEC available at www.sec.gov. If
any of these risks materialize or any of the Company’s assumptions
prove incorrect, actual results could differ materially from the
results implied by these forward-looking statements. There may be
additional risks that the Company presently does not know or that
it currently believes are immaterial that could also cause actual
results to differ from those contained in the forward-looking
statements. All forward-looking statements contained in this press
release speak only as of the date they were made. Except to the
extent required by law, the Company undertakes no obligation to
update such statements to reflect events that occur or
circumstances that exist after the date on which they were
made.
Investor Relations Sioban Hickie, ICR,
Inc.DragonflyIR@icrinc.com
Media RelationsAmy Demuth, RAD Strategies
Inc.media@radstrategiesinc.com
Source: Dragonfly Energy Holdings Corp.
Dragonfly Energy (NASDAQ:DFLI)
Historical Stock Chart
From Apr 2024 to May 2024
Dragonfly Energy (NASDAQ:DFLI)
Historical Stock Chart
From May 2023 to May 2024